Profile
THMO TEM CON ARDT ELUT MOTS
Company Name ThermoGenesis Holdings, Inc. Tempus AI, Inc. Class A Common Stock Concentra Group Holdings Parent, Inc. Ardent Health Partners, LLC Elutia Inc. Motus GI Holdings, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Market Cap $3.01M $6.91B $2.89B $2.43B $104.04M $428.06K
Employees 0.03K 0.00K 8.90K 18.60K 0.05K 0.02K
CEO Dr. Xiaochun Xu M.B.A., Ph.D. Mr. Eric P. Lefkofsky Mr. William Keith Newton Mr. Martin J. Bonick FACHE, M.H.A. Dr. C. Randal Mills Ph.D. Mr. Mark Pomeranz
Ratings
THMO TEM CON ARDT ELUT MOTS
Quant Rating Score 2 3 1
Quant Rating Sell Neutral Strong Sell
Trading
THMO TEM CON ARDT ELUT MOTS
Last Close $0.19 $41.92 $22.86 $17.24 $3.78 $0.067
High 52 $1.39 $43 $22.82 $17.3 $4.6 $5.65
Low 52 $0.13 $24.97 $22.57 $16.52 $3.75 $0.04
Price vs. 52 Week High -86.33 % -2.51 % 0.18 % -0.35 % -17.83 % -98.81 %
Price vs. 52 Week Low 46.15 % 67.88 % 1.28 % 4.36 % 0.8 % 67.5 %
Total Return
THMO TEM CON ARDT ELUT MOTS
1 Month Return -13.64 % 35.75 % 0 % 0 % 0 % 11.67 %
3 Month Return -72.06 % 0 % 0 % 0 % 0 % -17.28 %
6 Month Return -50 % 0 % 0 % 0 % 0 % -93.26 %
9 Month Return -82.88 % 0 % 0 % 0 % 0 % -83.66 %
YTD Return -68.39 % 0 % 0 % 0 % 0 % -94.75 %
1 Year Return -85.61 % 0 % 0 % 0 % 0 % -89.03 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
THMO TEM CON ARDT ELUT MOTS
Dividend Yield Percentage (TTM) - - - - - -
Dividend Paid and Capex Coverage Ration (TTM) -3.68 % - - - - -132.54 %
Dividend Per Share (TTM) - - - - - -
Payout Ratio (TTM) - - - - - -
Growth
THMO TEM CON ARDT ELUT MOTS
Asset Growth -42.06 % -59.07 %
Gross Profit Growth -28.75 % -188.48 %
Revenue Growth -9.9 % -46.11 %
Revenue 3 Year -94.29 % -56.95 %
Revenue 5 Year -98.31 % -44.77 %
Revenue 10 Year -99.93 % -
EBIT Growth -39.03 % 33.3 %
Net Income Growth -59.49 % 28.88 %
Net Income 3 Yeari Growth Per Share 93.52 % 91.32 %
Net Income 5 Yeari Growth Per Share 99.22 % 96.4 %
Net Income 10 Yeari Growth Per Share 99.76 % 86.23 %
Operating Income Growth -39.03 % 33.3 %
Operating Cash Flow Growth (CFG) 48.91 % 34.77 %
Operating 3 Year CFG 98.48 % 91.13 %
Operating 5 Year CFG 99.08 % 95.24 %
Operating 10 Year CFG 99.95 % 85.16 %
EPS Growth 62.89 % 81.04 %
EPS Diluted Growth 62.89 % 81.04 %
Book Value Per Share -109.03 % -75.93 %
Share Holder 3 Year Equity Growth Per Share -101.69 % -96.85 %
Share Holder 5 Year Equity Growth Per Share -100.34 % -99.1 %
Share Holder 10 Year Equity Growth Per Share -100 % 104.63 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth 1.84 % -78.42 %
Free Cash Flow Growth 29.01 % 35.01 %
Updated On 31 Dec 2023 31 Dec 2023
Profitability
THMO TEM CON ARDT ELUT MOTS
Gross Profit Margin TTM 21.1 % -48.93 %
Return on Assets TTM -146.18 % -120.04 %
Return on Equity TTM -762.31 % -1466.82 %
Return on Capital Employed TTM -455.52 % -254.83 %
Net Income Per EBT TTM 93.69 % 100 %
EBT Per Ebit TTM 193.77 % 88.59 %
EBIT Per Revenue TTM -84.52 % -2927.83 %
Cash Flow To Debt Ratio TTM -47.72 % -353.36 %
Receivables Turnover TTM 8.36 4.04
Payables Turnover TTM 7.67 -
Inventory Turnover TTM 6.09 2.14
Fixed Asset Turnover TTM 175.36 % 31.08 %
Asset Turnover TTM 95.27 % 4.63 %
Operating Cash Flow Per Share TTM -0.9 -1
Free Cash Flow Per Share TTM -1.14 -1.01
Cash Per Share TTM 29.21 % 57.4 %
Operating Cash Flow Sales Ratio TTM -37.58 % -2634.56 %
Free Cash Flow Operating Cash Flow Ratio TTM 127.19 % 100.75 %
Cash Flow Coverage Ratios TTM -47.72 % -353.36 %
Price To Free Cash Flows Ratio TTM -0.66 -0.05
Price To Operating Cash Flows Ratio TTM -0.21 -0.07
Price Cash Flow Ratio TTM -0.21 -0.07
Income Statement (TTM)
THMO TEM CON ARDT ELUT MOTS
Revenue $0.01B $0B
Gross Profit $0B $-0B
Gross Profit Ratio 20.44% -184.48%
EBITDA $-0.01B $-0.01B
Net Income $-0.02B $-0.01B
EPS Diluted -7.59 -15.89
Balance Sheet (MRQ)
THMO TEM CON ARDT ELUT MOTS
Long Term Debt $0B $0B
Total Liabilities $0.01B $0B
Total Equity $-0B $0B
Total Investments $0B $0B
Total Debt $0.01B $0B
Total Assets $0.01B $0.01B
Cash Flow Statement (TTM)
THMO TEM CON ARDT ELUT MOTS
Net Income $-0.02B $-0.01B
Inventory $0B $0B
Dividends Paid $0B $0B
Operating Cash Flow $-0B $-0.01B
Capital Expenditure $-0B $-0B
Related Stocks
Ticker Name Price
ARDT Ardent Health Partners, LLC 17.24
CON Concentra Group Holdings Parent, Inc. 22.86
ELUT Elutia Inc. 3.78
MOTS Motus GI Holdings, Inc. 0.067
TEM Tempus AI, Inc. Class A Common Stock 41.92
ETFs With Exposure to THMO
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 119.77
VXF Vanguard Extended Market Index Fund 0 178.79
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 135.6
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 135.6
VEMPX Vanguard Extended Market Index InstlPlus 0 334.63
Unlock